Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DR. REDDYS LAB BIOCON /
DR. REDDYS LAB
 
P/E (TTM) x 19.7 19.7 99.9% View Chart
P/BV x 1.8 4.4 40.6% View Chart
Dividend Yield % 0.6 0.6 87.4%  

Financials

 BIOCON    DR. REDDYS LAB
EQUITY SHARE DATA
    BIOCON
Mar-23
DR. REDDYS LAB
Mar-23
BIOCON /
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3884,656 8.3%   
Low Rs1923,788 5.1%   
Sales per share (Unadj.) Rs93.11,481.4 6.3%  
Earnings per share (Unadj.) Rs5.4270.7 2.0%  
Cash flow per share (Unadj.) Rs14.6345.7 4.2%  
Dividends per share (Unadj.) Rs1.5040.00 3.8%  
Avg Dividend yield %0.50.9 54.6%  
Book value per share (Unadj.) Rs146.51,389.6 10.5%  
Shares outstanding (eoy) m1,200.60166.53 721.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.12.8 109.2%   
Avg P/E ratio x54.115.6 346.8%  
P/CF ratio (eoy) x19.812.2 162.2%  
Price / Book Value ratio x2.03.0 65.1%  
Dividend payout %28.014.8 189.5%   
Avg Mkt Cap Rs m347,814703,039 49.5%   
No. of employees `000NANA-   
Total wages/salary Rs m21,81046,466 46.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,742246,697 45.3%  
Other income Rs m7,68110,555 72.8%   
Total revenues Rs m119,423257,252 46.4%   
Gross profit Rs m16,61163,860 26.0%  
Depreciation Rs m11,13112,502 89.0%   
Interest Rs m4,1901,428 293.4%   
Profit before tax Rs m8,97160,485 14.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,54115,412 16.5%   
Profit after tax Rs m6,43045,073 14.3%  
Gross profit margin %14.925.9 57.4%  
Effective tax rate %28.325.5 111.2%   
Net profit margin %5.818.3 31.5%  
BALANCE SHEET DATA
Current assets Rs m123,340203,161 60.7%   
Current liabilities Rs m85,10785,721 99.3%   
Net working cap to sales %34.247.6 71.9%  
Current ratio x1.42.4 61.1%  
Inventory Days Days12979 162.8%  
Debtors Days Days117107 108.8%  
Net fixed assets Rs m394,078112,638 349.9%   
Share capital Rs m6,003833 720.6%   
"Free" reserves Rs m169,926230,571 73.7%   
Net worth Rs m175,929231,404 76.0%   
Long term debt Rs m152,9051,278 11,964.4%   
Total assets Rs m517,418315,799 163.8%  
Interest coverage x3.143.4 7.2%   
Debt to equity ratio x0.90 15,737.1%  
Sales to assets ratio x0.20.8 27.6%   
Return on assets %2.114.7 13.9%  
Return on equity %3.719.5 18.8%  
Return on capital %4.026.6 15.0%  
Exports to sales %3.152.2 5.9%   
Imports to sales %6.016.8 35.4%   
Exports (fob) Rs m3,467128,803 2.7%   
Imports (cif) Rs m6,65441,484 16.0%   
Fx inflow Rs m3,467128,803 2.7%   
Fx outflow Rs m6,65441,484 16.0%   
Net fx Rs m-3,18787,319 -3.6%   
CASH FLOW
From Operations Rs m18,52558,875 31.5%  
From Investments Rs m-142,818-41,373 345.2%  
From Financial Activity Rs m130,487-26,861 -485.8%  
Net Cashflow Rs m6,411-9,073 -70.7%  

Share Holding

Indian Promoters % 40.4 26.7 151.4%  
Foreign collaborators % 20.3 0.0 -  
Indian inst/Mut Fund % 21.1 47.3 44.6%  
FIIs % 6.6 28.6 22.9%  
ADR/GDR % 0.0 15.3 -  
Free float % 39.4 58.0 67.8%  
Shareholders   434,339 257,794 168.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Biocon vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Dr. Reddys Share Price Performance

Period Biocon Dr. Reddys S&P BSE HEALTHCARE
1-Day 2.92% 1.78% 1.18%
1-Month -2.53% -4.23% -0.75%
1-Year 30.52% 35.93% 61.82%
3-Year CAGR -13.55% 10.85% 18.16%
5-Year CAGR -2.73% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of Biocon, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.